Phage Therapy Investigated for Cystic Fibrosis
Enrollment has begun in an early-stage clinical trial evaluating phage therapy (bacteriophage) in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.
Category: Cystic fibrosis
Cystic fibrosis
Latest
Cystic fibrosis
Latest
Study: Restoring the Airways’ Seal in CF
Using a model reproducing a respiratory epithelium, teams from the University of Geneva have discovered that a film of liquid is sufficient to restore the airways' seal and lower the risk of bacterial infection.
Cystic fibrosis
Latest
The Impact of BMI on Post-Lung Transplant Recovery in CF Patients
Researchers investigated how BMI corresponds with recovery after lung transplants in CF patients.
Best Practices in Pediatric Aerosol Therapy
Nebulizing medication for pediatric patients is an effective maintenance therapy for chronic lung conditions like asthma or cystic fibrosis; and yet medication adherence remains a major concern.
Read More
No FEV1 Benefit for Vigorous Exercise in Cystic Fibrosis Patients
A study published in the American Journal of Respiratory and Critical Care Medicine investigated how increased vigorous physical activity impacted lung function for sedentary patients with cystic fibrosis.
Read More
Difficulty Breathing and Cystic Fibrosis
Concerns over difficulty breathing have the greatest impact on cystic fibrosis patients’ decision-making with respect to the treatment of pulmonary exacerbations, research in the Journal of Cystic Fibrosis shows.
Read More
Proteins Influence Cystic Fibrosis
A new study has identified hundreds of new proteins that could play a role in cystic fibrosis, and which may provide new insights on why some patients respond better than others to current therapies.
Read More
SpliSense Cystic Fibrosis Drug Undergoes Clinical Trials
The FDA has granted orphan drug designation to the SpliSense cystic fibrosis drug SPL84-23, an ASO (antisense oligonucleotide).
Read More
Positive Response to Salbutamol Inhalation in Cystic Fibrosis Patients
A Swiss study recently published in Respiration found that bronchodilator inhalation with salbutamol is likely to have a positive short-term effect on forced expiratory volume in pediatric patients with cystic fibrosis.
Read More
Cystic Fibrosis Telemedicine Successful
New data looks at how the rapid implementation of telemedicine to assist in the care of cystic fibrosis patients was successful for monitoring lung function and identifying exacerbations during the COVID-19 pandemic.
Read More
The Distinct Cystic Fibrosis Airway Microbiota
There are distinct differences in airway microbiota and inflammation in the lower airways of cystic fibrosis patients, new research shows.
Read More
Pulmocide Receives Investment From the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is investing $3.5 million for the development of Pulmocide’s inhaled drug to prevent pulmonary aspergillosis infection in lung transplant recipients.
Read More
Gender Impacts Cystic Fibrosis Exacerbations
Women with CF have higher rates of pulmonary exacerbations compared with men and those differences appear early in life.
Read More
The Human Lung Airway Chip That Models Cystic Fibosis
A multidisciplinary research team at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a microfluidic organ chip device the size of a USB memory stick that recapitulates key pathological hallmarks from CF patients.
Read More
Cystic Fibrosis Patients Have High Rates of Sleep Apnea
Children with cystic fibrosis are at an increased risk of obstructive sleep apnea, new research has found.
Read More